SCHEMBL7766834

SCHEMBL7766834

O=C(SCC1CC(CSC(=O)c2ccccc2)N(Cc2ccccc2)C1=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.40
TSHR P16473 2/20 0.40
CYP3A4 P08684 1/20 0.40
EP300 Q09472 1/20 0.39
EHMT2 Q96KQ7 1/20 0.39
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP2C9 P11712 1/20 0.36
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
MTNR1A P48039 3/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM3 P20309 1/20 0.34
DRD4 P21917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7761971 0.92 TP53 (0.42) CYP2C19TSHRCYP3A4MEN1KMT2A
SCHEMBL7762203 0.89 HDAC6 (0.44) TSHRCYP3A4MEN1KMT2AALDH1A1
SCHEMBL7765831 0.89 ACE (0.44) CYP2C19TSHRCYP3A4EHMT2MEN1
SCHEMBL7764939 0.78 EHMT2 (0.44) CYP2C19TSHRCYP3A4EHMT2MEN1
SCHEMBL7762178 0.76 CRBN (0.46) CYP2C19TSHRCYP3A4EHMT2MEN1
SCHEMBL7765837 0.72 EHMT2 (0.39) CYP2C19TSHRCYP3A4EHMT2MEN1
SCHEMBL6399159 0.72 CCR2 (0.49) HDAC1HDAC8HDAC6
SCHEMBL6399311 0.72 CCR2 (0.49) HDAC1HDAC8HDAC6
SCHEMBL6399165 0.72 CCR2 (0.49) HDAC1HDAC8HDAC6
SCHEMBL6398891 0.71 OPRD1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639566-B1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO LTD (JP) 2001-06-20 EP disclosed
US-5461158-A Immunodeficiency and autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
EP-0639566-A1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 EP disclosed